top of page

Free Biopharma Daily Stock Updates - 04/18/22

  • Writer: BPIQ
    BPIQ
  • Apr 18, 2022
  • 1 min read

$XBI $83.59 | -4.76%

BiopharmIQ offers pro members full access to FDA Catalyst Calendar, PDUFA's, Biotech Stock Ideas.

Covid Updates

$OCGN -5.8% Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America. source



Pipeline Updates

$ACAD -4.5% Acadia Pharmaceuticals Announces Top-Line Results from Phase 2 Study Evaluating ACP-044 for the Treatment of Acute Postoperative Pain source


$KNTE -5.0% Kinnate Biopharma Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of its FGFR Inhibitor Product Candidate, KIN-3248. source


$BDTX -2.6% Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer. source



Business Updates

$AFMD -5.7% Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares. source


$TRVN -7.42% Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund. source

Posted by FS/JM

 
 
 

Comments

bottom of page